Northeast Financial Consultants’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-4,629
| Closed | -$255K | – | 323 |
|
|
2022
Q4 | $255K | Sell |
4,629
-4,500
| -49% | -$248K | 0.02% | 262 |
|
|
2022
Q3 | $404K | Sell |
9,129
-9,000
| -50% | -$398K | 0.03% | 219 |
|
|
2022
Q2 | $884K | Hold |
18,129
| – | – | 0.06% | 144 |
|
|
2022
Q1 | $882K | Hold |
18,129
| – | – | 0.05% | 169 |
|
|
2021
Q4 | $773K | Sell |
18,129
-18,000
| -50% | -$768K | 0.05% | 179 |
|
|
2021
Q3 | $1.39M | Buy |
36,129
+746
| +2% | +$28.6K | 0.09% | 126 |
|
|
2021
Q2 | $999K | Buy |
+35,383
| New | +$999K | 0.07% | 160 |
|